期刊文献+

新城疫病毒对晚期恶性肿瘤的临床应用 被引量:5

Clinical application of Newcastle disease virus in advanced cancers
原文传递
导出
摘要 目的 观察新城疫病毒 (NDV)对晚期癌症的治疗效果。方法 NDV注入经 37℃孵育 10天的SPF种蛋尿囊液中扩增NDV病毒 ,培养 72小时后收集含有病毒的尿囊液 ,经超速离心等方法提纯 ;以血凝试验等方法测定其滴度和活性。采用NDV治疗 77例晚期癌症患者 ,比较治疗前后淋巴细胞亚群变化。结果 应用NDV治疗 77例晚期癌症患者 ,总有效率 19例 (2 4 .6 8% ) ;完全缓解 2例 (2 .6 0 % ) ,部分缓解 17例 (2 2 .0 8% ) ,稳定 4 5例 (5 8.4 5 % ) ,进展 13例 (16 .88% )。患者经NDV治疗后 ,NK细胞数量增加。结论 NDV治疗晚期癌症有一定的疗效 ,值得进一步研究。 Objective To observe the effect of Newcastle disease virus(NDV) on advanced cancer. Methods The NDV was injected into allantoic cavity of SPF hen's eggs that were hatched for 10 days in 37 ℃ for virus to replicate and expand. The allantoic liquid containing NDV was collected after vaccination for 72 hours and purified by the ways of superspeed centrifugatization. The activity of NDV was detected by the agglutination.The lymphocytes in peripheral blood were detected in 77 advanced cancer patients treated with NDV. Results The total response rate(CR+PR) in 77 patients was 19(24.68%),with 2(2.60%) complete response(CR),17(22.08%) partial response(PR),stable in 45(58.45%)NDV and progressive in 13(16.88%).The number of NK lymphocytes increased after treatment by NDV. Conclusion Newcastle disease virus is effective in treating advanced cancers,which is worth to further study.
出处 《中国综合临床》 北大核心 2004年第1期37-38,共2页 Clinical Medicine of China
基金 辽宁省重点科研经费资助项目 (8952 1 5)
关键词 新城疫病毒 恶性肿瘤 晚期 副作用 Newcastle disease virus Advanced benign cancer Side effect
  • 相关文献

参考文献1

  • 1Thomas Schneider,Roswitha Gerhards,Elmar Kirches,Raimund Firsching. Preliminary Results of Active Specific Immunization with Modified Tumor Cell Vaccine in Glioblastoma Multiforme[J] 2001,Journal of Neuro - Oncology(1):39~46

同被引文献75

  • 1李东复,杨贵贞,王亮.肝癌患者癌组织与外周血Th1/Th2细胞的监测及临床意义[J].中国免疫学杂志,2004,20(10):720-722. 被引量:1
  • 2张沛怡,曹殿军,胡立华.新城疫病毒杀伤肝癌细胞的体外研究[J].中华肝脏病杂志,2005,13(6):467-468. 被引量:2
  • 3杜柏权,于源华,赵然,牛灵.Bcl-2/C-Raf双基因“敲低”抑制人结肠癌细胞增殖[J].中国生物化学与分子生物学报,2007,23(4):298-303. 被引量:1
  • 4Joseph GS, Joseph CH. Newcastle disease virus (NDV): brief history of its oncolytic strains. Journal of Clinical Virology,2000, 16:1 - 15.
  • 5Csatary LK. Viruses in the treatment of cancer. Lancet, 1971, 2:825.
  • 6Cassel WA, Murray DR. A ten-year follow-up on stage H malignant melanoma patients treated postsurgically with Newcsatle disease virus oncolysate. Medical Oncology and Tumor Pharmacotherapy, 1992, 9 : 169 - 171.
  • 7Csatary LK, Gosztonyi G, Szeberenyi J,et al. MTH-68/H oneolytic viral treatment in human high-grade gliomas. Journal of Neurooncology, 2004, 67 : 83 - 93.
  • 8Lorence RM, Roberts MS, O' Neil JD, et al. Overview of phase Ⅰ studies of intravenous adminstration of PV701, an oncolytic virus. Current Opinion in Molecular Therapeutics, 2003,5:618 - 624.
  • 9Songahu Meng, Zhengming Chen, Munoz-Antonia T, et al. Participation of both Gabl and Gab2 are in the activation of the Erk mitrogen-activated protein kinase pathway by epidermal growth factor. The Biochemical Journal, 2005, 391:143- 151.
  • 10S Szeberenyi J, Fabian Z, Torocsik B, et al. Newcastle disease virus-induced apoptosis in PC12 pheochromocytoma cells. American Journal of Therapeutics, 2003, 10:282 - 288.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部